IL6 and breast carcinoma: This phenomenon was also evident in breast cancer when breast cancer cells secreted a number of factors, such as transforming growth factor-β1 (TGF-β1), interleukin 1 (IL-1), IL-6 and IL-1114,39–41, all of which suppressed osteoblast differentiation and function.